Leaderboards/breast cancer treatment studies

breast cancer treatment studies

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Erica Stringer-Reasor
University of Alabama at Birmingham
99
2
Barbara O’Brien
The University of Texas MD Anderson Cancer Center
80
3
Wendy R. Parulekar
Queen's University
60
4
E Jishna
International Institute for Population Sciences
40
5
Toshinari Yamashita
Kanagawa Prefectural Hospital Organization
30
6
Min Yan
Henan Cancer Hospital
20
7
Yajing Feng
Zhengzhou University
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Lena Cords
University of Zurich
80
2
Giulia Viale
Istituti di Ricovero e Cura a Carattere Scientifico
60
3
Shanu Modi
Memorial Sloan Kettering Cancer Center
40
4
Renée Schmitz
The Netherlands Cancer Institute
30
5
Padakanti Sandeep Chary
National Institute of Pharmaceutical Education and Research
20
6
Tabassum Wadasadawala
Homi Bhabha National Institute
10

Emerging Leaders Papers

1
Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer
Cancer Cell|2024
246 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Ada Braun
National Cancer Centre Japan
99
2
Howard Yeh
Hospital de Santa Maria
80
3
Neil K. Aaronson
Unknown
70
4
Chris Twelves
University of Leeds
60
5
Gilles Romieu
Mount Vernon Hospital
50
6
Gϋnter von Minckwitz
Düsseldorf University Hospital
40
7
Alison Jones
Roche (Switzerland)
30
8
Joyce O’Shaughnessy
Texas Oncology
20
9
Emiel J. Rutgers
European Organisation for Research and Treatment of Cancer
10

All-Time Leaders Papers

1
Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer
Journal of Clinical Oncology|2010
960 cit.
2
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
British Journal of Cancer|2006
257 cit.
3
Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort
ESMO Open|2016
13 cit.
4
Cellular Uptake and Efflux of Palbociclib In Vitro in Single Cell and Spheroid Models
Journal of Pharmacology and Experimental Therapeutics|2019
11 cit.

Indexing breast cancer treatment studies Reagents

Citation data for reagents in this field is currently compiling.